Holen Sie sich die Stockscreener-App
13.92
0.43%
0.06
Handel nachbörslich:
14.19
0.27
+1.94%
Schlusskurs vom Vortag:
$13.86
Offen:
$13.98
24-Stunden-Volumen:
208.82K
Relative Volume:
0.66
Marktkapitalisierung:
$686.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-91.76M
KGV:
-2.5522
EPS:
-5.4541
Netto-Cashflow:
$-94.89M
1W Leistung:
-0.93%
1M Leistung:
-7.39%
6M Leistung:
+80.78%
1J Leistung:
+0.00%
1-Tages-Spanne:
$13.55
$14.42
1-Wochen-Bereich:
$13.38
$15.32
52-Wochen-Spanne:
$6.565
$17.71
Jade Biosciences Inc Stock (JBIO) Company Profile
Firmenname
Jade Biosciences Inc
Sektor
Branche
Telefon
(781) 312-3013
Adresse
221 CRESCENT ST., WALTHAM
Compare JBIO vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JBIO
Jade Biosciences Inc
|
13.92 | 683.50M | 0 | -91.76M | -94.89M | -5.4541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-10-09 | Eingeleitet | BTIG Research | Buy |
| 2025-07-14 | Eingeleitet | Jefferies | Buy |
| 2025-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2025-05-07 | Eingeleitet | Wedbush | Outperform |
| 2025-05-05 | Eingeleitet | Stifel | Buy |
| 2025-05-02 | Eingeleitet | TD Cowen | Buy |
| 2024-06-18 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-06-18 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-06-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-06-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-06-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-03-25 | Fortgesetzt | Jefferies | Buy |
| 2023-12-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-01 | Eingeleitet | Guggenheim | Buy |
| 2022-12-06 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Outperform |
| 2022-08-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-02-11 | Eingeleitet | BTIG Research | Buy |
| 2021-07-26 | Eingeleitet | Cowen | Outperform |
| 2021-07-26 | Eingeleitet | Evercore ISI | Outperform |
| 2021-07-26 | Eingeleitet | Jefferies | Buy |
| 2021-07-26 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Jade Biosciences Inc Aktie (JBIO) Neueste Nachrichten
Jade Biosciences (NASDAQ:JBIO) Stock Price Expected to Rise, Guggenheim Analyst Says - Defense World
Jade Biosciences (NASDAQ:JBIO) Cut to Strong Sell at Zacks Research - Defense World
Zacks Research Downgrades Jade Biosciences (NASDAQ:JBIO) to Strong Sell - MarketBeat
Guggenheim Forecasts Strong Price Appreciation for Jade Biosciences (NASDAQ:JBIO) Stock - MarketBeat
Guggenheim raises Jade Biosciences stock price target on pipeline progress By Investing.com - Investing.com Canada
William Blair Upgrades Jade Biosciences (NASDAQ:JBIO) to Strong-Buy - Defense World
Jade Biosciences (NASDAQ:JBIO) Sees Large Volume Increase Following Analyst Upgrade - Defense World
Jade Biosciences (NASDAQ:JBIO) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Raised to "Strong-Buy" at William Blair - MarketBeat
TD Cowen reiterates Jade Biosciences stock rating on APRIL data By Investing.com - Investing.com Canada
William Blair initiates Jade Biosciences stock coverage with Outperform rating - Investing.com UK
Trading Recap: Is Jade Biosciences Inc a speculative investment2026 Breakouts & Accurate Buy Signal Alerts - baoquankhu1.vn
Wedbush Reaffirms Outperform Rating for Jade Biosciences (NASDAQ:JBIO) - MarketBeat
William Blair initiates Jade Biosciences stock coverage with Outperform rating By Investing.com - Investing.com South Africa
Signal Recap: Is Jade Biosciences Inc a speculative investment2026 Historical Comparison & Weekly Stock Performance Updates - baoquankhu1.vn
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Raised to “Strong-Buy” at Lifesci Capital - Defense World
Jade Biosciences (NASDAQ:JBIO) Upgraded by Lifesci Capital to "Strong-Buy" Rating - MarketBeat
Jade 10-K: $127.4M net loss, cash and investments $336.2M - TradingView
BTIG reiterates Buy on Jade Biosciences stock, $28 target maintained By Investing.com - Investing.com Canada
Stifel raises Jade Biosciences price target on IgAN market outlook - Investing.com
Jade Biosciences reports fourth quarter and full year 2025 financial results and provides corporate update - marketscreener.com
Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - The Manila Times
Jade Biosciences Stock Quote, Share Price, News and Analysis - Longbridge
Jade Biosciences Touts “Best-in-Class” Autoimmune Antibodies, JADE101 Phase 1 Readout Nears - Defense World
JBIO Should I Buy - Intellectia AI
JBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Oppenheimer 36th Healthcare Life Sciences Conference: Spotlight On LGND, PHAR, CRBP, Among Others - RTTNews
Chipmakers Recap: Is Jade Biosciences Inc a stock for growth or value investors2025 Top Gainers & Long-Term Investment Growth Plans - baoquankhu1.vn
Can Jade Biosciences Inc. expand its profit marginsWeekly Profit Recap & Safe Entry Zone Tips - mfd.ru
Jade Biosciences (JBIO) grants RSUs and 247,500-share option to officer - Stock Titan
Weekly Earnings: Is Jade Biosciences Inc a speculative investmentJuly 2025 Spike Watch & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Jade Biosciences to Participate in Upcoming Conferences - Yahoo Finance
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Shares Gap UpHere's Why - MarketBeat
Jade Biosciences, Inc. (NASDAQ:JBIO) Short Interest Update - MarketBeat
Aug Sentiment: Is Jade Biosciences Inc a speculative investment2025 Top Gainers & Long-Term Investment Growth Plans - baoquankhu1.vn
Jade Biosciences (NASDAQ:JBIO) Trading Up 8.1%What's Next? - MarketBeat
Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know - MSN
Jade Biosciences (NASDAQ:JBIO) Stock Price Down 5.3%Here's What Happened - MarketBeat
Economics Weekly : There's Something About Kevin - William Blair
What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock - MSN
H.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue - Finviz
Short Interest in Jade Biosciences, Inc. (NASDAQ:JBIO) Increases By 47.9% - MarketBeat
Jade Biosciences, Inc. (NASDAQ:JBIO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Breakout Watch: What is AvePoint Incs TAM Total Addressable MarketMarket Trend Report & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
JBIO: Advancing novel autoimmune therapies with strong data, market potential, and rapid clinical timelines - TradingView
Valuation Update: What is the PEG ratio of Jade Biosciences IncJuly 2025 PostEarnings & AI Enhanced Trading Alerts - baoquankhu1.vn
Jade Biosciences (NASDAQ:JBIO) Trading Down 4.8%Should You Sell? - MarketBeat
Published on: 2026-01-10 20:20:04 - ulpravda.ru
How risky is Jade Biosciences Inc. stock nowPortfolio Profit Report & Fast Entry and Exit Trade Plans - Улправда
Finanzdaten der Jade Biosciences Inc-Aktie (JBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):